Furthermore, in a group of 67 MDS patients, high levels of p53 expression (≥10% of the cells) were associated with TP53 mutations, increased BM blast counts, low-risk karyotypes, and most importantly, decreased OS (27). Here, TP53 is linked to myelodysplastic syndrome.